Manejo de la infección por candida en el recién nacido

Worldwide, neonatal mortality corresponds to 41% of those that occur in children under five years of age. Among the causes described by WHO, sepsis corresponds to the third, after prematurity and perinatal asphyxia. Candida sp is one of the etiological agents that in the neonatal period generates high morbidity and mortality, as well as long-term neurological sequelae, especially in premature and low birth weight. These patients have their own immunological characteristics, requirements for invasive procedures and greater survival in prolonged hospital stays, which become risk factors that predispose to develop systemic candidiasis. Given the impact of this pathology, it is important to have a comprehensive diagnostic and therapeutic approach that reduces morbidity and mortality, improving vital and functional prognosis. In recent years, different medical guidelines and protocols have been generated in order to optimize the management of this infection, so it is important to describe what are the best current recommendations for the approach, diagnosis and treatment of neonatal candidiasis.

• Publication year

  2015

• Venue

  Repertorio de Medicina y Cirugía

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.31260/REPERTMEDCIR.V24.N2.2015.633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neonatal candidiasis.

  2020cited by this paper
• Invasive Candidiasis.

  2019influential reference
• Risk factors of late-onset neonatal sepsis in Taiwan: A matched case-control study.

  2016cited by this paper
• Favorable Outcome of Neonatal Cerebrospinal Fluid Shunt-Associated Candida Meningitis with Caspofungin

  2013cited by this paper
• [Recommendations for the management of candidemia in neonates in Latin America. Grupo Proyecto Épico].

  2013cited by this paper
• Neonatal Endogenous Endophthalmitis: A Report of Six Cases

  2013cited by this paper
• The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009

  2013influential reference
• Neonatal infectious diseases: evaluation of neonatal sepsis.

  2013cited by this paper
• Safety of fluconazole in paediatrics: a systematic review

  2013cited by this paper
• Time to Initiation of Antifungal Therapy for Neonatal Candidiasis

  2013cited by this paper
• Neonatal candidemia: a changing trend.

  2012cited by this paper
• Candida virulence properties and adverse clinical outcomes in neonatal candidiasis.

  2012cited by this paper
• Antifungal therapy for newborn infants with invasive fungal infection.

  2012cited by this paper
• Fluconazole pharmacokinetics and safety in premature infants.

  2012cited by this paper
• The use of antifungal therapy in neonatal intensive care.

  2012cited by this paper
• Neonatal fungal infections: when to treat?

  2012cited by this paper
• Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates

  2012cited by this paper
• Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

  2012cited by this paper
• Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.

  2012cited by this paper
• Outcomes following candiduria in extremely low birth weight infants.

  2012cited by this paper
• A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

  2012cited by this paper
• "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.

  2012cited by this paper
• Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease

  2011cited by this paper
• Candida infections in non-neutropenic children after the neonatal period

  2011cited by this paper
• Epidemiology and management of candidaemia – a retrospective, multicentre study in five hospitals in the UK

  2011cited by this paper
• [The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis].

  2011cited by this paper
• Invasive candidiasis in neonates and children.

  2011cited by this paper
• Strategies to prevent invasive candidal infection in extremely preterm infants.

  2010cited by this paper
• Invasive fungal infections in neonatal intensive care units of Southern Italy: a multicentre regional active surveillance (AURORA project).

  2010influential reference
• Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome

  2010cited by this paper
• Fluconazole to Prevent Systemic Fungal Infections in Infants: Reviewing the Evidence

  2010cited by this paper
• Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment

  2010cited by this paper
• Invasive Fungal Infections in Pediatric Patients: Challenges to Optimal Management

  2010cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Candida colonisation as a source for candidaemia.

  2009cited by this paper
• Prevention and treatment of invasive fungal infection in very low birthweight infants

  2008cited by this paper
• Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit.

  2008cited by this paper
• Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species

  2008cited by this paper
• Fungal Prophylaxis in the Neonatal Intensive Care Unit

  2008cited by this paper
• Antifungal prophylaxis for the prevention of neonatal candidiasis?

  2008cited by this paper
• A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

  2007cited by this paper
• Prevention and treatment of Candida infections in neonates.

  2007cited by this paper
• Caspofungin for the treatment of azole resistant candidemia in a premature infant

  2007cited by this paper
• Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

  2006cited by this paper
• Changing Incidence of Candida Bloodstream Infections Among NICU Patients in the United States: 1995–2004

  2006cited by this paper
• Risk factors for candidemia in critically ill infants: a matched case-control study.

  2005influential reference
• Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

  2002cited by this paper
• Risk factors for candidemia in Neonatal Intensive Care Unit patients

  2000cited by this paper

• No citing papers are available for this paper.